TY - JOUR
T1 - Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens
AU - Lopes, Rui
AU - Sprouffske, Kathleen
AU - Sheng, Caibin
AU - Uijttewaal, Esther C H
AU - Wesdorp, Adriana Emma
AU - Dahinden, Jan
AU - Wengert, Simon
AU - Diaz-Miyar, Juan
AU - Yildiz, Umut
AU - Bleu, Melusine
AU - Apfel, Verena
AU - Mermet-Meillon, Fanny
AU - Krese, Rok
AU - Eder, Mathias
AU - Olsen, André Vidas
AU - Hoppe, Philipp
AU - Knehr, Judith
AU - Carbone, Walter
AU - Cuttat, Rachel
AU - Waldt, Annick
AU - Altorfer, Marc
AU - Naumann, Ulrike
AU - Weischenfeldt, Joachim
AU - deWeck, Antoine
AU - Kauffmann, Audrey
AU - Roma, Guglielmo
AU - Schübeler, Dirk
AU - Galli, Giorgio G
N1 - Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
PY - 2021/7
Y1 - 2021/7
N2 - Millions of putative transcriptional regulatory elements (TREs) have been cataloged in the human genome, yet their functional relevance in specific pathophysiological settings remains to be determined. This is critical to understand how oncogenic transcription factors (TFs) engage specific TREs to impose transcriptional programs underlying malignant phenotypes. Here, we combine cutting edge CRISPR screens and epigenomic profiling to functionally survey ≈15,000 TREs engaged by estrogen receptor (ER). We show that ER exerts its oncogenic role in breast cancer by engaging TREs enriched in GATA3, TFAP2C, and H3K27Ac signal. These TREs control critical downstream TFs, among which TFAP2C plays an essential role in ER-driven cell proliferation. Together, our work reveals novel insights into a critical oncogenic transcription program and provides a framework to map regulatory networks, enabling to dissect the function of the noncoding genome of cancer cells.
AB - Millions of putative transcriptional regulatory elements (TREs) have been cataloged in the human genome, yet their functional relevance in specific pathophysiological settings remains to be determined. This is critical to understand how oncogenic transcription factors (TFs) engage specific TREs to impose transcriptional programs underlying malignant phenotypes. Here, we combine cutting edge CRISPR screens and epigenomic profiling to functionally survey ≈15,000 TREs engaged by estrogen receptor (ER). We show that ER exerts its oncogenic role in breast cancer by engaging TREs enriched in GATA3, TFAP2C, and H3K27Ac signal. These TREs control critical downstream TFs, among which TFAP2C plays an essential role in ER-driven cell proliferation. Together, our work reveals novel insights into a critical oncogenic transcription program and provides a framework to map regulatory networks, enabling to dissect the function of the noncoding genome of cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=85109278247&partnerID=8YFLogxK
U2 - 10.1126/sciadv.abf5733
DO - 10.1126/sciadv.abf5733
M3 - Journal article
C2 - 34215580
SN - 2375-2548
VL - 7
JO - Science Advances
JF - Science Advances
IS - 27
M1 - eabf5733
ER -